Literature DB >> 17198768

A better future for patients with restless legs syndrome.

John W Winkelman1.   

Abstract

Despite advances in the management of restless legs syndrome (RLS), there still is a great deal of uncertainty about its etiology, pathophysiology, therapy, and clinical outcomes. Much remains to be learned. Future research on these issues will help identify the optimum therapeutic approach for the diverse group of patients with RLS.

Entities:  

Mesh：

Year:  2007        PMID： 17198768     DOI： 10.1016/j.amjmed.2006.11.005

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


  2 in total

1.  A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

Authors:  Daniel O Lee; Ronald B Ziman; A Thomas Perkins; J Steven Poceta; Arthur S Walters; Ronald W Barrett
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

2.  [Socioeconomic relevance of the idiopathic restless legs syndrome (RLS) in Germany: cost-of-illness study].

Authors:  Sandra Nelles; Juliane Köberlein; Christine Grimm; David Pittrow; Wilhelm Kirch; Reinhard Rychlik
Journal:  Med Klin (Munich)       Date:  2009-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.